Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: Relationship with clinical data

Clinical Microbiology and Infection

Volumn 16, Issue 7, 2010, Pages 878-884

  Esteves, F ^a   Gaspar, J ^b   Marques, T ^c   Leite, R ^d   Antunes, F ^c   Mansinho, K ^d   Matos, O ^a  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b NOVA MEDICAL SCHOOL   (Portugal)

^c HOSPITAL DE SANTA MARIA   (Portugal)

^d HOSPITAL EGAS MONIZ   (Portugal)

Author keywords

AIDS; Clinical data; Pneumocystis jirovecii; Pneumonia; SNPs

Indexed keywords

COTRIMOXAZOLE; CYTOCHROME B; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; LARGE SUBUNIT RIBOSOMAL RNA; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FOLLOW UP; FUNGAL COLONIZATION; FUNGAL VIRULENCE; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII;

EID: 77954634399     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03030.x     Document Type: Article

References (37)

1. Redhead SA, Cushion MT, Frenkel JK, Stringer JR. Pneumocystis and Trypanosoma cruzi: nomenclature and typifications. J Eukaryot Microbiol 2006, 53:2-11.
2. Beck JM, Cushion MT. Pneumocystis workshop: 10th anniversary summary. Eukaryot Cell 2009, 8:446-460.
3. Thomas CF, Limper AH. Current insights into the biology and pathogenesis of Pneumocystis pneumonia. Nat Rev Microbiol 2007, 5:298-308.
4. Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin Infect Dis 2008, 46:625-633.
5. Morris A, Lundgren JD, Masur H. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004, 10:1713-1720.
6. Barry SM, Johnson MA. Pneumocystis carinii pneumonia: a review of current issues in diagnosis and management. HIV Med 2001, 2:123-132.
7. Crothers K, Beard CB, Turner J. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 2005, 19:801-805.
8. Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999, 354:1347-1351.
9. Miller RF, Wakefield AE. Pneumocystis carinii genotypes and severity of pneumonia. Lancet 1999, 353:2039-2040.
10. Miller RF, Evans HE, Copas AJ, Cassell JA. Climate and genotypes of Pneumocystis jirovecii. Clin Microbiol Infect 2007, 13:445-448.
11. Olsson M, Lidman C, Latouche S. Identification of Pneumocystis carinii f. sp. hominis gene sequences in filtered air in hospital environments. J Clin Microbiol 1998, 36:1737-1740.
12. Hauser PM, Sudre P, Nahimana A, Francioli P. Prophylaxis failure is associated with a specific Pneumocystis carinii genotype. Clin Infect Dis 2001, 33:1080-1082.
13. Faber A, Ferreira GN, Silva SN, Rueff J, Gaspar J. Multiplex PCR-single-base extension genotyping of multiple glutathione S-transferase polymorphisms. Biotechnol Appl Biochem 2005, 41:9-15.
14. Kim S, Misra A. SNP genotyping: technologies and biomedical applications. Annu Rev Biomed Eng 2007, 9:289-320.
15. Matos O, Costa MC, Lundgren B, Caldeira L, Aguiar P, Antunes F. Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections. Eur J Clin Microbiol Infect Dis 2001, 20:573-575.
16. Beard CB, Roux P, Nevez G. Strain typing methods and molecular epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004, 10:1729-1735.
17. Costa MC, Gaspar J, Mansinho K, Esteves F, Antunes F, Matos O. Detection of Pneumocystis jirovecii dihydropteroate synthase polymorphisms in patients with Pneumocystis pneumonia. Scand J Infect Dis 2005, 37:766-771.
18. Costa MC, Esteves F, Antunes F, Matos O. Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal. J Antimicrob Chemother 2006, 58:1246-1249.
19. Kazanjian P, Armstrong W, Hossler PA. Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS. J Infect Dis 2001, 183:819-822.
20. Miller RF, Lindley AR, Malin AS, Ambrose HE, Wakefield AE. Isolates of Pneumocystis jirovecii from Harare show high genotypic similarity to isolates from London at the superoxide dismutase locus. Trans R Soc Trop Med Hyg 2005, 99:202-206.
21. Esteves F, Montes-Cano MA, de la Horra C. Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin Microbiol Infect 2008, 14:356-362.
22. Wakefield AE, Pixley FJ, Banerji S. Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol 1990, 43:69-76.
23. Esteves F, Tavares A, Costa MC, Gaspar J, Antunes F, Matos O. Genetic characterization of the UCS and Kex1 loci of Pneumocystis jirovecii. Eur J Clin Microbiol Infect Dis 2009, 28:175-178.
24. Daffertshofer A, Lamoth CJ, Meijer OG, Beek PJ. PCA in studying coordination and variability: a tutorial. Clin Biomech (Bristol, Avon) 2004, 19:415-428.
25. Noller HF. Structure of ribosomal RNA. Annu Rev Biochem 1984, 53:119-162.
26. Walker DJ, Wakefield AE, Dohn MN. Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure. J Infect Dis 1998, 178:1767-1775.
27. Denis CM, Mazars E, Guyot K. Genetic divergence at the SODA locus of six different formae speciales of Pneumocystis carinii. Med Mycol 2000, 38:289-300.
28. Denis CM, Guyot K, Wakefield AE. Molecular cloning and characterization of a superoxide dismutase (sod) gene in Pneumocystis carinii. J Eukaryot Microbiol 1998, 45:475-483.
29. Wakefield AE, Lindley AR, Ambrose HE, Denis CM, Miller RF. Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients. J Infect Dis 2003, 187:901-908.
30. Kimchi-Sarfaty C, Oh JM, Kim IW. A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science 2007, 315:525-528.
31. Shen LX, Basilion JP, Stanton VP. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci USA 1999, 96:7871-7876.
32. Schnell JR, Dyson HJ, Wright PE. Structure, dynamics, and catalytic function of dihydrofolate reductase. Annu Rev Biophys Biomol Struct 2004, 33:119-140.
33. Kazanjian P, Armstrong W, Hossler PA. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 2000, 182:551-557.
34. Costa MC, Esteves F, Antunes F, Matos O. Multilocus genotyping of Pneumocystis jirovecii in immunocompromised patients: preliminary results. J Eukaryot Microbiol 2006, 53(suppl 1):S104-S105.
35. Ma L, Borio L, Masur H, Kovacs JA. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J Infect Dis 1999, 180:1969-1978.
36. Kang D, Hamasaki N. Mitochondrial oxidative stress and mitochondrial DNA. Clin Chem Lab Med 2003, 41:1281-1288.
37. Matos O, Lee CH, Jin S. Pneumocystis jiroveci in Portuguese immunocompromised patients: association of specific ITS genotypes with treatment failure, bad clinical outcome and childhood. Infect Genet Evol 2003, 3:281-285.